DANIEL JANSE

Profile

First Name

: DANIEL

Middle Name

:

Last Name

: JANSE

Related Companies

Titles

Company Name

Related People

DIRECTOR

ARO BIOTHERAPEUTICS CO

ELIZABETH ANDERSON, SUSAN B DILLON, MITTIE DOYLE, SAAN-CHIRAG GANDHI, SCOTT GREENBERG, MARK LAURENZI, MARK V. LAURENZI, JESS LIFTON, CHRISTOPHER MIRABELLI, KARYN O-NEIL, BRUCE PEACOCK, KEVIN RAIDY, MARTEN STEEN

DIRECTOR

TRIUMVIRA IMMUNOLOGICS INC.

BRIAN M. BLOOM, CYNTHIA COLLINS, MBA, LEE COOPER, JURGEN ECKHARDT, SHAAN C. GANDHI, MD, DPHIL, JON IRVIN, PAUL LAMMERS, MD, MSC, TERESA MCROBERTS, WIDYA MULYASASMITA, SCOTT SMITH, ELIZABETH WILLIAMS, ELIZABETH C. WILLIAMS

DIRECTOR

WALKING FISH THERAPEUTICS, INC.

FRANKLIN BERGER, FRANKLIN M. BERGER, ANTONIN DE FOUGEROLLES, ALEXIS JI, MANISH KOTHARI, LEWIS T. WILLIAMS, MOMO WU, STELLA XU

DIRECTOR

ENPLUSONE BIOSCIENCES INC.

DANIEL AHLSTEDT, STEVEN KASOK, ANDREW LEE, PAXTON MAJOR, DANIEL WIEGAND

DIRECTOR

GARUDA THERAPEUTICS, INC.

ERIC AGUIAR, ADAM CRAIG, SHAAN GANDHI, CARL GORDON, RAYMOND KELLEHER, DAVID KIRSKE, STEVE LIAPIS, GEOFF MEYERSON, LAURENCE REID, DHVANIT I SHAH, RAHUL SINGHVI

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2023-04-10

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2023-01-23

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2022-12-13

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2022-08-30

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2021-04-26

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2021-04-26

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2022-02-16

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2021-04-26

D/A

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2020-12-21